SR One Capital Management’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22M | Hold |
6,526,476
| – | – | 4.77% | 7 |
|
|
2025
Q1 | $25.2M | Hold |
6,526,476
| – | – | 6.47% | 6 |
|
|
2024
Q4 | $40.3M | Hold |
6,526,476
| – | – | 9.82% | 4 |
|
|
2024
Q3 | $35.1M | Hold |
6,526,476
| – | – | 7.04% | 5 |
|
|
2024
Q2 | $21.9M | Hold |
6,526,476
| – | – | 6.85% | 6 |
|
|
2024
Q1 | $26.3M | Hold |
6,526,476
| – | – | 7.22% | 5 |
|
|
2023
Q4 | $17.3M | Hold |
6,526,476
| – | – | 7.26% | 3 |
|
|
2023
Q3 | $15.4M | Hold |
6,526,476
| – | – | 7.89% | 3 |
|
|
2023
Q2 | $41.1M | Hold |
6,526,476
| – | – | 17.73% | 2 |
|
|
2023
Q1 | $37.7M | Hold |
6,526,476
| – | – | 14.03% | 2 |
|
|
2022
Q4 | $67M | Buy |
6,526,476
+900,000
| +16% | +$9.23M | 24.44% | 2 |
|
|
2022
Q3 | $94.1M | Hold |
5,626,476
| – | – | 43.01% | 2 |
|
|
2022
Q2 | $78.8M | Hold |
5,626,476
| – | – | 38.55% | 2 |
|
|
2022
Q1 | $90.9M | Hold |
5,626,476
| – | – | 46.52% | 1 |
|
|
2021
Q4 | $120M | Buy |
+5,626,476
| New | +$120M | 68.08% | 1 |
|